Page last updated: 2024-11-04

rofecoxib and Atrial Fibrillation

rofecoxib has been researched along with Atrial Fibrillation in 3 studies

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research Excerpts

ExcerptRelevanceReference
" Our patient had arthritis of the hips and chronic atrial fibrillation and was on warfarin therapy for stroke prevention; less than a week after starting celecoxib therapy, gastrointestinal bleeding and hypoprothrombinemia occurred."3.70Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia. ( Davis, JV; Linder, JD; Mönkemüller, KE; Wilcox, CM, 2000)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bäck, M1
Yin, L1
Ingelsson, E1
Khan, FY1
Hassan, IF1
Allity, MH1
Khan, SM1
Linder, JD1
Mönkemüller, KE1
Davis, JV1
Wilcox, CM1

Other Studies

3 other studies available for rofecoxib and Atrial Fibrillation

ArticleYear
Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib.
    European heart journal, 2012, Volume: 33, Issue:15

    Topics: Atrial Fibrillation; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Epidemiologic

2012
Retroperitoneal hematoma following rofecoxib and enoxaparin coadministration in a patient with atrial fibrillation.
    Saudi medical journal, 2005, Volume: 26, Issue:2

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Comorbidity; Cyclooxygenase Inhibitors; Enoxaparin; Hemat

2005
Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia.
    Southern medical journal, 2000, Volume: 93, Issue:9

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthritis; Atrial Fibrillation; Bicar

2000